News
Approved! Wanbangde Pharmaceutical Group's Lidocaine Hydrochloride Injection Passes Consistency Evaluation
Date:
21 Feb,2024
Recently, Wanbangde Pharmaceutical Group Co., Ltd. received approval and issuance from the National Medical Products Administration regarding Lidocaine Hydrochloride Injection (Dosage: 5 ml; 0.1 g) — The "Drug Supplementary Application Approval Notice" confirms that the company's submitted "Lidocaine Hydrochloride Injection (Registration Category: Chemical Drug)" has successfully passed the bioequivalence evaluation for generic drugs, following review by the National Medical Products Administration.
About Lidocaine Hydrochloride Injection
Lidocaine Hydrochloride Injection is a local anesthetic. And Anti-arrhythmic medication Primarily used for infiltration anesthesia, epidural anesthesia, and surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery), as well as nerve conduction block. It can also be used after acute myocardial infarction. Ventricular premature beats Japanese-style room Supraventricular tachycardia, also applicable in cases of digitalis toxicity, cardiac surgery complications, and those induced by cardiac catheterization. Ventricular arrhythmia It is listed as a Class A item in the National Medical Insurance Catalogue (2023 edition).
About Wanbande Pharmaceutical Group
Founded in 1970 and headquartered in Wenling, Zhejiang, Wanbangde Pharmaceutical Group is a high-tech enterprise dedicated to the research, development, manufacturing, and marketing of modern Chinese medicine, as well as chemical APIs and formulations. Over the years, the company has consistently pursued an integrated approach that combines industry, academia, and research, boasting a well-established technology transfer platform. Focusing primarily on therapeutic areas such as cardiovascular and cerebrovascular diseases, as well as neurological disorders, Wanbangde has developed a product portfolio characterized by natural herbal medicines, with cardiovascular and neurological treatments forming the core offerings, complemented by medications for respiratory and other conditions. The company also proudly features two proprietary products—Ginkgo Biloba Dropping Pills—as key assets in its intellectual property portfolio. Huperzine A Injection 。
Related Recommendations